9VC fundamentals
An in-depth look to atai Life Sciences B.V. operating, investing, and financing activities
9VC free cash flow for Q1 24 is -20.92 M EUR. For 2023, 9VC free cash flow was -76.45 M EUR and operating cash flow was -76.21 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM